Casdin Capital’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-106,000
| Closed | -$19.1M | – | 28 |
|
|
2017
Q3 | $19.1M | Buy |
106,000
+16,000
| +18% | +$2.88M | 5.38% | 8 |
|
|
2017
Q2 | $9.33M | Buy |
90,000
+47,500
| +112% | +$4.92M | 3.45% | 10 |
|
|
2017
Q1 | $3.34M | Sell |
42,500
-51,500
| -55% | -$4.04M | 1.97% | 17 |
|
|
2016
Q4 | $4.22M | Buy |
94,000
+4,000
| +4% | +$179K | 3.48% | 12 |
|
|
2016
Q3 | $5.03M | Buy |
90,000
+17,500
| +24% | +$977K | 4.07% | 10 |
|
|
2016
Q2 | $3.63M | Sell |
72,500
-2,500
| -3% | -$125K | 3.61% | 11 |
|
|
2016
Q1 | $3.44M | Buy |
75,000
+45,000
| +150% | +$2.07M | 3.95% | 12 |
|
|
2015
Q4 | $1.85M | Buy |
+30,000
| New | +$1.85M | 1.63% | 20 |
|